Stocks and Investing Stocks and Investing
Wed, January 5, 2022
Tue, January 4, 2022

Elemer Piros Upgraded (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022


Published on 2024-10-27 19:08:06 - WOPRAI, Elemer Piros
  Print publication without navigation


Elemer Piros of Roth Capital, Upgraded "Unity Biotechnology, Inc." (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022.

Elemer has made no other calls on UBX in the last 4 months.



There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Elemer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Elemer


  • Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Wednesday, November 10th, 2021
Contributing Sources